ACADIA Pharmaceuticals Inc. (ACAD) financial statements (2020 and earlier)

Company profile

Business Address 3611 VALLEY CENTRE DRIVE
SAN DIEGO, CA 92130
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments697684382414474214257
Cash and cash equivalents19038574981356474
Short-term investments508298307317339150183
Receivables38323334282127
Inventory, net of allowances, customer advances and progress billings6545445
Inventory6545445
Prepaid expense19211924211513
Total current assets:760742437476526254301
Noncurrent Assets
Operating lease, right-of-use asset1010  
Property, plant and equipment3334333
Intangible assets, net (including goodwill)3334445
Intangible assets, net (excluding goodwill)3334445
Restricted cash and investments5555533
Other noncurrent assets3222213
Other undisclosed noncurrent assets  1111   
Total noncurrent assets:23232425141214
TOTAL ASSETS:783766461501540266315
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities75686475604249
Accounts payable7353333
Accrued liabilities68645972563946
Total current liabilities:75686475604249
Noncurrent Liabilities
Long-term debt and lease obligation66     
Operating lease, liability66  
Liabilities, other than long-term debt3211   
Other liabilities3211   
Other undisclosed noncurrent liabilities  77211
Total noncurrent liabilities:9988211
Total liabilities:84767283614350
Stockholders' equity
Stockholders' equity attributable to parent699689389418479223265
Common stock0000000
Additional paid in capital2,4032,3401,9971,9721,9481,6271,606
Accumulated other comprehensive income (loss)0010(0)(0)(1)
Accumulated deficit(1,704)(1,651)(1,609)(1,554)(1,469)(1,403)(1,341)
Total stockholders' equity:699689389418479223265
TOTAL LIABILITIES AND EQUITY:783766461501540266315

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues98958363605857
Cost of revenue(6)(4)(5)(4)(6)(5)(5)
Cost of goods and services sold(3)(2)(3)(3)7(4)(4)
Other undisclosed gross profit8   6  
Gross profit:100907959605352
Operating expenses(148)(136)(136)(146)(121)(115)(116)
Other undisclosed operating loss(8)   (6)  
Operating loss:(56)(45)(57)(88)(67)(61)(64)
Nonoperating income (expense)11(0)(0)(2)(2)(0)
Investment income, nonoperating1   (2)  
Other nonoperating income (expense)01(0)(0)0(2)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes10   7  
Loss from continuing operations before equity method investments, income taxes:(45)(45)(57)(88)(62)(63)(64)
Other undisclosed income (loss) from continuing operations before income taxes(8)233(4)11
Loss from continuing operations before income taxes:(53)(42)(55)(85)(65)(62)(63)
Income tax expense (benefit)(0)0(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(53)(42)(55)(85)(65)(62)(63)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(53)(42)(55)(85)(65)(62)(63)
Other undisclosed comprehensive income1   0  
Comprehensive loss:(52)(42)(55)(85)(65)(62)(63)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(0)01(0)00
Comprehensive loss, net of tax, attributable to parent:(53)(42)(55)(85)(66)(62)(63)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: